The U.S. antiseptic and disinfectant market size was valued at USD 9.41 billion in 2024 and is projected to reach USD 17.07 billion by 2030, growing at a CAGR of 10.8% from 2025 to 2030. An increase in the prevalence of diseases, such as influenza, hepatitis A, typhoid, cholera, and dengue, is one of the major factors driving the antiseptic & disinfectant market growth.
According to the Centers for Disease Control and Prevention (CDC), the 2023 - 2024 flu season led to an estimated 40 million illnesses, 470,000 hospitalizations, and 28,000 deaths in the U.S. The need for effective disinfection in both healthcare and community settings drives the U.S. antiseptic and disinfectant industry. The increasing number of surgical and inpatient medical procedures in the U.S. significantly drives demand for antiseptics and disinfectants. Each procedure requires stringent sterilization protocols and aseptic practices to minimize the risk of healthcare-associated infections. The growing prevalence of chronic diseases and an aging population are contributing to higher hospitalization rates. This sustained patient volume increases surface contamination risks, reinforcing the need for consistent and effective disinfection practices across healthcare facilities.
Regulatory organizations such as the U.S. Environmental Protection Agency (EPA) and the Food and Drug Administration (FDA) play a vital role in shaping the U.S. industry. These agencies enforce strict standards for product efficacy, safety, and labeling, particularly in healthcare environments. The EPA mandates that hospital-grade disinfectants undergo rigorous testing to prove effectiveness against a broad range of pathogens. Meanwhile, the FDA oversees the safety and formulation of antiseptics used on patients. This regulatory environment encourages manufacturers to innovate and drives healthcare providers to adopt compliant, high-quality disinfection solutions.
This product will be delivered within 2 business days.
According to the Centers for Disease Control and Prevention (CDC), the 2023 - 2024 flu season led to an estimated 40 million illnesses, 470,000 hospitalizations, and 28,000 deaths in the U.S. The need for effective disinfection in both healthcare and community settings drives the U.S. antiseptic and disinfectant industry. The increasing number of surgical and inpatient medical procedures in the U.S. significantly drives demand for antiseptics and disinfectants. Each procedure requires stringent sterilization protocols and aseptic practices to minimize the risk of healthcare-associated infections. The growing prevalence of chronic diseases and an aging population are contributing to higher hospitalization rates. This sustained patient volume increases surface contamination risks, reinforcing the need for consistent and effective disinfection practices across healthcare facilities.
Regulatory organizations such as the U.S. Environmental Protection Agency (EPA) and the Food and Drug Administration (FDA) play a vital role in shaping the U.S. industry. These agencies enforce strict standards for product efficacy, safety, and labeling, particularly in healthcare environments. The EPA mandates that hospital-grade disinfectants undergo rigorous testing to prove effectiveness against a broad range of pathogens. Meanwhile, the FDA oversees the safety and formulation of antiseptics used on patients. This regulatory environment encourages manufacturers to innovate and drives healthcare providers to adopt compliant, high-quality disinfection solutions.
U.S. Antiseptic And Disinfectant Market Report Segmentation
This report forecasts revenue growth at the country level and analyzes the latest industry trends in each of the sub-segments from 2018 to 2030. For this study, the analyst has segmented the U.S. antiseptic and disinfectant market report based on type, product type, end use, and sales channel:Type Outlook (Revenue, USD Million, 2018 - 2030)
- Quaternary Ammonium Compounds
- Chlorine Compounds
- Alcohols & Aldehyde Products
- Enzyme
- Others
Product Type Outlook (Revenue, USD Million, 2018 - 2030)
- Enzymatic Cleaners
- Medical Device Disinfectants
- Surface Disinfectants
End Use Outlook (Revenue, USD Million, 2018 - 2030)
- Hospitals
- Clinics
- Other
Sales Channel Outlook (Revenue, USD Million, 2018 - 2030)
- B2B
- FMCG
Why should you buy this report?
- Comprehensive Market Analysis: Gain detailed insights into the global market across major regions and segments.
- Competitive Landscape: Explore the market presence of key players worldwide.
- Future Trends: Discover the pivotal trends and drivers shaping the future of the global market.
- Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.
This report addresses:
- Market intelligence to enable effective decision-making
- Market estimates and forecasts from 2018 to 2030
- Growth opportunities and trend analyses
- Segment and regional revenue forecasts for market assessment
- Competition strategy and market share analysis
- Product innovation listing for you to stay ahead of the curve
- COVID-19's impact and how to sustain in these fast-evolving markets
This product will be delivered within 2 business days.
Table of Contents
Chapter 1. Methodology and Scope
Chapter 2. Executive Summary
Chapter 3. U.S. Antiseptic And Disinfectant Market Variables, Trends and Scope
Chapter 4. U.S. Antiseptic And Disinfectant Market: Type Estimates and Trend Analysis
Chapter 5. U.S. Antiseptic And Disinfectant Market: Product Type Estimates and Trend Analysis
Chapter 6. U.S. Antiseptic And Disinfectant Market: End Use Estimates and Trend Analysis
Chapter 7. U.S. Antiseptic And Disinfectant Market: Sales Channel Estimates and Trend Analysis
Chapter 8. Competitive Landscape
List of Tables
List of Figures
Companies Mentioned
- 3M
- RECKITT BENCKISER GROUP PLC
- Steris Plc
- Kimberly-Clark Worldwide, Inc.
- Bio-Cide International, Inc. (Kemin Industries, Inc.)
- Cardinal Health
- BD
- Johnson & Johnson
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 80 |
| Published | July 2025 |
| Forecast Period | 2024 - 2030 |
| Estimated Market Value ( USD | $ 9.41 Billion |
| Forecasted Market Value ( USD | $ 17.07 Billion |
| Compound Annual Growth Rate | 10.8% |
| Regions Covered | United States |
| No. of Companies Mentioned | 8 |
